IBDEI029 ; ; 01-MAY-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 01, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5087,1,3,0)
 ;;=3^Shortness of breath
 ;;^UTILITY(U,$J,358.3,5087,1,4,0)
 ;;=4^R06.02
 ;;^UTILITY(U,$J,358.3,5087,2)
 ;;=^5019181
 ;;^UTILITY(U,$J,358.3,5088,0)
 ;;=R06.82^^34^310^20
 ;;^UTILITY(U,$J,358.3,5088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5088,1,3,0)
 ;;=3^Tachypnea, not elsewhere classified
 ;;^UTILITY(U,$J,358.3,5088,1,4,0)
 ;;=4^R06.82
 ;;^UTILITY(U,$J,358.3,5088,2)
 ;;=^5019191
 ;;^UTILITY(U,$J,358.3,5089,0)
 ;;=R06.2^^34^310^21
 ;;^UTILITY(U,$J,358.3,5089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5089,1,3,0)
 ;;=3^Wheezing
 ;;^UTILITY(U,$J,358.3,5089,1,4,0)
 ;;=4^R06.2
 ;;^UTILITY(U,$J,358.3,5089,2)
 ;;=^5019184
 ;;^UTILITY(U,$J,358.3,5090,0)
 ;;=R06.00^^34^310^10
 ;;^UTILITY(U,$J,358.3,5090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5090,1,3,0)
 ;;=3^Dyspnea, unspecified
 ;;^UTILITY(U,$J,358.3,5090,1,4,0)
 ;;=4^R06.00
 ;;^UTILITY(U,$J,358.3,5090,2)
 ;;=^5019180
 ;;^UTILITY(U,$J,358.3,5091,0)
 ;;=R06.1^^34^310^19
 ;;^UTILITY(U,$J,358.3,5091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5091,1,3,0)
 ;;=3^Stridor
 ;;^UTILITY(U,$J,358.3,5091,1,4,0)
 ;;=4^R06.1
 ;;^UTILITY(U,$J,358.3,5091,2)
 ;;=^5019183
 ;;^UTILITY(U,$J,358.3,5092,0)
 ;;=R05.^^34^310^8
 ;;^UTILITY(U,$J,358.3,5092,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5092,1,3,0)
 ;;=3^Cough
 ;;^UTILITY(U,$J,358.3,5092,1,4,0)
 ;;=4^R05.
 ;;^UTILITY(U,$J,358.3,5092,2)
 ;;=^5019179
 ;;^UTILITY(U,$J,358.3,5093,0)
 ;;=R07.1^^34^310^7
 ;;^UTILITY(U,$J,358.3,5093,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5093,1,3,0)
 ;;=3^Chest pain on breathing
 ;;^UTILITY(U,$J,358.3,5093,1,4,0)
 ;;=4^R07.1
 ;;^UTILITY(U,$J,358.3,5093,2)
 ;;=^5019196
 ;;^UTILITY(U,$J,358.3,5094,0)
 ;;=R07.81^^34^310^14
 ;;^UTILITY(U,$J,358.3,5094,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5094,1,3,0)
 ;;=3^Pleurodynia
 ;;^UTILITY(U,$J,358.3,5094,1,4,0)
 ;;=4^R07.81
 ;;^UTILITY(U,$J,358.3,5094,2)
 ;;=^5019198
 ;;^UTILITY(U,$J,358.3,5095,0)
 ;;=R91.1^^34^310^18
 ;;^UTILITY(U,$J,358.3,5095,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5095,1,3,0)
 ;;=3^Solitary pulmonary nodule
 ;;^UTILITY(U,$J,358.3,5095,1,4,0)
 ;;=4^R91.1
 ;;^UTILITY(U,$J,358.3,5095,2)
 ;;=^5019707
 ;;^UTILITY(U,$J,358.3,5096,0)
 ;;=R91.8^^34^310^1
 ;;^UTILITY(U,$J,358.3,5096,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5096,1,3,0)
 ;;=3^Abnormal Finding of Lung Field,Nonspecific NEC
 ;;^UTILITY(U,$J,358.3,5096,1,4,0)
 ;;=4^R91.8
 ;;^UTILITY(U,$J,358.3,5096,2)
 ;;=^5019708
 ;;^UTILITY(U,$J,358.3,5097,0)
 ;;=R93.1^^34^310^2
 ;;^UTILITY(U,$J,358.3,5097,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5097,1,3,0)
 ;;=3^Abnormal findings on dx imaging of heart and cor circ
 ;;^UTILITY(U,$J,358.3,5097,1,4,0)
 ;;=4^R93.1
 ;;^UTILITY(U,$J,358.3,5097,2)
 ;;=^5019714
 ;;^UTILITY(U,$J,358.3,5098,0)
 ;;=R76.12^^34^310^12
 ;;^UTILITY(U,$J,358.3,5098,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5098,1,3,0)
 ;;=3^Nonspec reaction to gamma intrfrn respns w/o actv tubrclosis
 ;;^UTILITY(U,$J,358.3,5098,1,4,0)
 ;;=4^R76.12
 ;;^UTILITY(U,$J,358.3,5098,2)
 ;;=^5019571
 ;;^UTILITY(U,$J,358.3,5099,0)
 ;;=R09.01^^34^310^5
 ;;^UTILITY(U,$J,358.3,5099,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5099,1,3,0)
 ;;=3^Asphyxia
 ;;^UTILITY(U,$J,358.3,5099,1,4,0)
 ;;=4^R09.01
 ;;^UTILITY(U,$J,358.3,5099,2)
 ;;=^11005
 ;;^UTILITY(U,$J,358.3,5100,0)
 ;;=R09.02^^34^310^11
 ;;^UTILITY(U,$J,358.3,5100,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5100,1,3,0)
 ;;=3^Hypoxemia
 ;;^UTILITY(U,$J,358.3,5100,1,4,0)
 ;;=4^R09.02
 ;;^UTILITY(U,$J,358.3,5100,2)
 ;;=^332831
 ;;^UTILITY(U,$J,358.3,5101,0)
 ;;=Z86.718^^34^310^13
 ;;^UTILITY(U,$J,358.3,5101,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5101,1,3,0)
 ;;=3^Personal history of other venous thrombosis and embolism
 ;;^UTILITY(U,$J,358.3,5101,1,4,0)
 ;;=4^Z86.718
 ;;^UTILITY(U,$J,358.3,5101,2)
 ;;=^5063475
 ;;^UTILITY(U,$J,358.3,5102,0)
 ;;=U07.1^^34^310^9
 ;;^UTILITY(U,$J,358.3,5102,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5102,1,3,0)
 ;;=3^Covid-19 Acute Respiratory Disease
 ;;^UTILITY(U,$J,358.3,5102,1,4,0)
 ;;=4^U07.1
 ;;^UTILITY(U,$J,358.3,5102,2)
 ;;=^5159070
 ;;^UTILITY(U,$J,358.3,5103,0)
 ;;=E08.9^^34^311^31
 ;;^UTILITY(U,$J,358.3,5103,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5103,1,3,0)
 ;;=3^Diabetes due to underlying condition w/o complications
 ;;^UTILITY(U,$J,358.3,5103,1,4,0)
 ;;=4^E08.9
 ;;^UTILITY(U,$J,358.3,5103,2)
 ;;=^5002544
 ;;^UTILITY(U,$J,358.3,5104,0)
 ;;=E09.9^^34^311^61
 ;;^UTILITY(U,$J,358.3,5104,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5104,1,3,0)
 ;;=3^Drug/chem induced diabetes mellitus w/o complications
 ;;^UTILITY(U,$J,358.3,5104,1,4,0)
 ;;=4^E09.9
 ;;^UTILITY(U,$J,358.3,5104,2)
 ;;=^5002586
 ;;^UTILITY(U,$J,358.3,5105,0)
 ;;=E08.65^^34^311^1
 ;;^UTILITY(U,$J,358.3,5105,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5105,1,3,0)
 ;;=3^Diabetes due to underlying condition w hyperglycemia
 ;;^UTILITY(U,$J,358.3,5105,1,4,0)
 ;;=4^E08.65
 ;;^UTILITY(U,$J,358.3,5105,2)
 ;;=^5002541
 ;;^UTILITY(U,$J,358.3,5106,0)
 ;;=E09.65^^34^311^58
 ;;^UTILITY(U,$J,358.3,5106,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5106,1,3,0)
 ;;=3^Drug/chem induced diabetes mellitus w hyperglycemia
 ;;^UTILITY(U,$J,358.3,5106,1,4,0)
 ;;=4^E09.65
 ;;^UTILITY(U,$J,358.3,5106,2)
 ;;=^5002583
 ;;^UTILITY(U,$J,358.3,5107,0)
 ;;=E08.10^^34^311^2
 ;;^UTILITY(U,$J,358.3,5107,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5107,1,3,0)
 ;;=3^Diabetes due to underlying condition w ketoacidosis w/o coma
 ;;^UTILITY(U,$J,358.3,5107,1,4,0)
 ;;=4^E08.10
 ;;^UTILITY(U,$J,358.3,5107,2)
 ;;=^5002505
 ;;^UTILITY(U,$J,358.3,5108,0)
 ;;=E09.10^^34^311^41
 ;;^UTILITY(U,$J,358.3,5108,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5108,1,3,0)
 ;;=3^Drug/chem diabetes w ketoacidosis w/o coma
 ;;^UTILITY(U,$J,358.3,5108,1,4,0)
 ;;=4^E09.10
 ;;^UTILITY(U,$J,358.3,5108,2)
 ;;=^5002547
 ;;^UTILITY(U,$J,358.3,5109,0)
 ;;=E08.01^^34^311^3
 ;;^UTILITY(U,$J,358.3,5109,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5109,1,3,0)
 ;;=3^Diabetes due to underlying condition w hyprosm w coma
 ;;^UTILITY(U,$J,358.3,5109,1,4,0)
 ;;=4^E08.01
 ;;^UTILITY(U,$J,358.3,5109,2)
 ;;=^5002504
 ;;^UTILITY(U,$J,358.3,5110,0)
 ;;=E09.01^^34^311^37
 ;;^UTILITY(U,$J,358.3,5110,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5110,1,3,0)
 ;;=3^Drug/chem diabetes w hyperosmolarity w coma
 ;;^UTILITY(U,$J,358.3,5110,1,4,0)
 ;;=4^E09.01
 ;;^UTILITY(U,$J,358.3,5110,2)
 ;;=^5002546
 ;;^UTILITY(U,$J,358.3,5111,0)
 ;;=E08.11^^34^311^4
 ;;^UTILITY(U,$J,358.3,5111,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5111,1,3,0)
 ;;=3^Diabetes due to underlying condition w ketoacidosis w coma
 ;;^UTILITY(U,$J,358.3,5111,1,4,0)
 ;;=4^E08.11
 ;;^UTILITY(U,$J,358.3,5111,2)
 ;;=^5002506
 ;;^UTILITY(U,$J,358.3,5112,0)
 ;;=E08.641^^34^311^5
 ;;^UTILITY(U,$J,358.3,5112,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5112,1,3,0)
 ;;=3^Diabetes due to underlying condition w hypoglycemia w coma
 ;;^UTILITY(U,$J,358.3,5112,1,4,0)
 ;;=4^E08.641
 ;;^UTILITY(U,$J,358.3,5112,2)
 ;;=^5002539
 ;;^UTILITY(U,$J,358.3,5113,0)
 ;;=E09.11^^34^311^40
 ;;^UTILITY(U,$J,358.3,5113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5113,1,3,0)
 ;;=3^Drug/chem diabetes w ketoacidosis w coma
 ;;^UTILITY(U,$J,358.3,5113,1,4,0)
 ;;=4^E09.11
 ;;^UTILITY(U,$J,358.3,5113,2)
 ;;=^5002548
 ;;^UTILITY(U,$J,358.3,5114,0)
 ;;=E09.641^^34^311^38
 ;;^UTILITY(U,$J,358.3,5114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5114,1,3,0)
 ;;=3^Drug/chem diabetes w hypoglycemia w coma
 ;;^UTILITY(U,$J,358.3,5114,1,4,0)
 ;;=4^E09.641
 ;;^UTILITY(U,$J,358.3,5114,2)
 ;;=^5002581
 ;;^UTILITY(U,$J,358.3,5115,0)
 ;;=E08.21^^34^311^6
 ;;^UTILITY(U,$J,358.3,5115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5115,1,3,0)
 ;;=3^Diabetes due to underlying condition w diabetic nephropathy
 ;;^UTILITY(U,$J,358.3,5115,1,4,0)
 ;;=4^E08.21
 ;;^UTILITY(U,$J,358.3,5115,2)
 ;;=^5002507
 ;;^UTILITY(U,$J,358.3,5116,0)
 ;;=E09.21^^34^311^34
 ;;^UTILITY(U,$J,358.3,5116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5116,1,3,0)
 ;;=3^Drug/chem diabetes w diabetic nephropathy
 ;;^UTILITY(U,$J,358.3,5116,1,4,0)
 ;;=4^E09.21
 ;;^UTILITY(U,$J,358.3,5116,2)
 ;;=^5002549
 ;;^UTILITY(U,$J,358.3,5117,0)
 ;;=E08.311^^34^311^7
 ;;^UTILITY(U,$J,358.3,5117,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5117,1,3,0)
 ;;=3^Diabetes due to underlying condition w unsp diabetic rtnop w macular edema
 ;;^UTILITY(U,$J,358.3,5117,1,4,0)
 ;;=4^E08.311
 ;;^UTILITY(U,$J,358.3,5117,2)
 ;;=^5002510
 ;;^UTILITY(U,$J,358.3,5118,0)
 ;;=E08.319^^34^311^8
 ;;^UTILITY(U,$J,358.3,5118,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5118,1,3,0)
 ;;=3^Diabetes due to underlying condition w unsp diab rtnop w/o macular edema
 ;;^UTILITY(U,$J,358.3,5118,1,4,0)
 ;;=4^E08.319
 ;;^UTILITY(U,$J,358.3,5118,2)
 ;;=^5002511
 ;;^UTILITY(U,$J,358.3,5119,0)
 ;;=E08.36^^34^311^9
 ;;^UTILITY(U,$J,358.3,5119,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5119,1,3,0)
 ;;=3^Diabetes due to underlying condition w diabetic cataract
 ;;^UTILITY(U,$J,358.3,5119,1,4,0)
 ;;=4^E08.36
 ;;^UTILITY(U,$J,358.3,5119,2)
 ;;=^5002520
 ;;^UTILITY(U,$J,358.3,5120,0)
 ;;=E08.39^^34^311^10
 ;;^UTILITY(U,$J,358.3,5120,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5120,1,3,0)
 ;;=3^Diabetes due to underlying condition w oth diabetic opth comp
 ;;^UTILITY(U,$J,358.3,5120,1,4,0)
 ;;=4^E08.39
 ;;^UTILITY(U,$J,358.3,5120,2)
 ;;=^5002521
 ;;^UTILITY(U,$J,358.3,5121,0)
 ;;=E09.311^^34^311^56
 ;;^UTILITY(U,$J,358.3,5121,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5121,1,3,0)
 ;;=3^Drug/chem diabetes w unsp diabetic rtnop w macular edema
 ;;^UTILITY(U,$J,358.3,5121,1,4,0)
 ;;=4^E09.311
 ;;^UTILITY(U,$J,358.3,5121,2)
 ;;=^5002552
 ;;^UTILITY(U,$J,358.3,5122,0)
 ;;=E09.319^^34^311^57
 ;;^UTILITY(U,$J,358.3,5122,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5122,1,3,0)
 ;;=3^Drug/chem diabetes w unsp diabetic rtnop w/o macular edema
 ;;^UTILITY(U,$J,358.3,5122,1,4,0)
 ;;=4^E09.319
 ;;^UTILITY(U,$J,358.3,5122,2)
 ;;=^5002553
 ;;^UTILITY(U,$J,358.3,5123,0)
 ;;=E09.36^^34^311^32
 ;;^UTILITY(U,$J,358.3,5123,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5123,1,3,0)
 ;;=3^Drug/chem diabetes w diabetic cataract
 ;;^UTILITY(U,$J,358.3,5123,1,4,0)
 ;;=4^E09.36
 ;;^UTILITY(U,$J,358.3,5123,2)
 ;;=^5002562
 ;;^UTILITY(U,$J,358.3,5124,0)
 ;;=E09.39^^34^311^51
 ;;^UTILITY(U,$J,358.3,5124,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5124,1,3,0)
 ;;=3^Drug/chem diabetes w oth diabetic ophthalmic complication
 ;;^UTILITY(U,$J,358.3,5124,1,4,0)
 ;;=4^E09.39
 ;;^UTILITY(U,$J,358.3,5124,2)
 ;;=^5002563
 ;;^UTILITY(U,$J,358.3,5125,0)
 ;;=E08.40^^34^311^11
 ;;^UTILITY(U,$J,358.3,5125,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5125,1,3,0)
 ;;=3^Diabetes due to underlying condition w diabetic neurop, unsp
 ;;^UTILITY(U,$J,358.3,5125,1,4,0)
 ;;=4^E08.40
 ;;^UTILITY(U,$J,358.3,5125,2)
 ;;=^5002522
 ;;^UTILITY(U,$J,358.3,5126,0)
 ;;=E08.41^^34^311^12
 ;;^UTILITY(U,$J,358.3,5126,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5126,1,3,0)
 ;;=3^Diabetes due to underlying condition w diabetic mononeuropathy
 ;;^UTILITY(U,$J,358.3,5126,1,4,0)
 ;;=4^E08.41
 ;;^UTILITY(U,$J,358.3,5126,2)
 ;;=^5002523
 ;;^UTILITY(U,$J,358.3,5127,0)
 ;;=E08.42^^34^311^13
 ;;^UTILITY(U,$J,358.3,5127,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5127,1,3,0)
 ;;=3^Diabetes due to underlying condition w diabetic polyneurop
 ;;^UTILITY(U,$J,358.3,5127,1,4,0)
 ;;=4^E08.42
 ;;^UTILITY(U,$J,358.3,5127,2)
 ;;=^5002524
 ;;^UTILITY(U,$J,358.3,5128,0)
 ;;=E08.43^^34^311^14
 ;;^UTILITY(U,$J,358.3,5128,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5128,1,3,0)
 ;;=3^Diabetes due to underlying condition w diabetic autonm (poly)neuropathy
 ;;^UTILITY(U,$J,358.3,5128,1,4,0)
 ;;=4^E08.43
 ;;^UTILITY(U,$J,358.3,5128,2)
 ;;=^5002525
 ;;^UTILITY(U,$J,358.3,5129,0)
 ;;=E08.44^^34^311^15
 ;;^UTILITY(U,$J,358.3,5129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5129,1,3,0)
 ;;=3^Diabetes due to underlying condition w diabetic amyotrophy
 ;;^UTILITY(U,$J,358.3,5129,1,4,0)
 ;;=4^E08.44
 ;;^UTILITY(U,$J,358.3,5129,2)
 ;;=^5002526
 ;;^UTILITY(U,$J,358.3,5130,0)
 ;;=E08.49^^34^311^16
 ;;^UTILITY(U,$J,358.3,5130,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5130,1,3,0)
 ;;=3^Diabetes due to underlying condition w oth diabetic neuro comp
 ;;^UTILITY(U,$J,358.3,5130,1,4,0)
 ;;=4^E08.49
 ;;^UTILITY(U,$J,358.3,5130,2)
 ;;=^5002527
 ;;^UTILITY(U,$J,358.3,5131,0)
 ;;=E08.610^^34^311^17
 ;;^UTILITY(U,$J,358.3,5131,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5131,1,3,0)
 ;;=3^Diabetes due to underlying condition w diabetic neuropathic arthrop
 ;;^UTILITY(U,$J,358.3,5131,1,4,0)
 ;;=4^E08.610
 ;;^UTILITY(U,$J,358.3,5131,2)
 ;;=^5002531
 ;;^UTILITY(U,$J,358.3,5132,0)
 ;;=E09.40^^34^311^43
 ;;^UTILITY(U,$J,358.3,5132,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5132,1,3,0)
 ;;=3^Drug/chem diabetes w neuro comp w diabetic neuropathy, unsp
 ;;^UTILITY(U,$J,358.3,5132,1,4,0)
 ;;=4^E09.40
 ;;^UTILITY(U,$J,358.3,5132,2)
 ;;=^5002564
 ;;^UTILITY(U,$J,358.3,5133,0)
 ;;=E09.41^^34^311^44
 ;;^UTILITY(U,$J,358.3,5133,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5133,1,3,0)
 ;;=3^Drug/chem diabetes w neuro comp w diabetic mononeuropathy
 ;;^UTILITY(U,$J,358.3,5133,1,4,0)
 ;;=4^E09.41
 ;;^UTILITY(U,$J,358.3,5133,2)
 ;;=^5002565
 ;;^UTILITY(U,$J,358.3,5134,0)
 ;;=E09.42^^34^311^46
 ;;^UTILITY(U,$J,358.3,5134,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5134,1,3,0)
 ;;=3^Drug/chem diabetes w neurological comp w diabetic polyneurop
 ;;^UTILITY(U,$J,358.3,5134,1,4,0)
 ;;=4^E09.42
 ;;^UTILITY(U,$J,358.3,5134,2)
 ;;=^5002566
 ;;^UTILITY(U,$J,358.3,5135,0)
 ;;=E09.43^^34^311^42
 ;;^UTILITY(U,$J,358.3,5135,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5135,1,3,0)
 ;;=3^Drug/chem diabetes w neuro comp w diab autonm (poly)neuropathy
 ;;^UTILITY(U,$J,358.3,5135,1,4,0)
 ;;=4^E09.43
 ;;^UTILITY(U,$J,358.3,5135,2)
 ;;=^5002567
 ;;^UTILITY(U,$J,358.3,5136,0)
 ;;=E09.44^^34^311^47
 ;;^UTILITY(U,$J,358.3,5136,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5136,1,3,0)
 ;;=3^Drug/chem diabetes w neurological comp w diabetic amyotrophy
 ;;^UTILITY(U,$J,358.3,5136,1,4,0)
 ;;=4^E09.44
 ;;^UTILITY(U,$J,358.3,5136,2)
 ;;=^5002568
 ;;^UTILITY(U,$J,358.3,5137,0)
 ;;=E09.49^^34^311^45
 ;;^UTILITY(U,$J,358.3,5137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5137,1,3,0)
 ;;=3^Drug/chem diabetes w neuro comp w oth diabetic neuro comp
 ;;^UTILITY(U,$J,358.3,5137,1,4,0)
 ;;=4^E09.49
 ;;^UTILITY(U,$J,358.3,5137,2)
 ;;=^5002569
 ;;^UTILITY(U,$J,358.3,5138,0)
 ;;=E09.610^^34^311^35
 ;;^UTILITY(U,$J,358.3,5138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5138,1,3,0)
 ;;=3^Drug/chem diabetes w diabetic neuropathic arthropathy
 ;;^UTILITY(U,$J,358.3,5138,1,4,0)
 ;;=4^E09.610
 ;;^UTILITY(U,$J,358.3,5138,2)
 ;;=^5002573
 ;;^UTILITY(U,$J,358.3,5139,0)
 ;;=E08.51^^34^311^18
 ;;^UTILITY(U,$J,358.3,5139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5139,1,3,0)
 ;;=3^Diabetes due to underlying condition w diab prph angiopath w/o gangrene
 ;;^UTILITY(U,$J,358.3,5139,1,4,0)
 ;;=4^E08.51
 ;;^UTILITY(U,$J,358.3,5139,2)
 ;;=^5002528
 ;;^UTILITY(U,$J,358.3,5140,0)
 ;;=E08.59^^34^311^19
 ;;^UTILITY(U,$J,358.3,5140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5140,1,3,0)
 ;;=3^Diabetes due to underlying condition w oth circulatory comp
 ;;^UTILITY(U,$J,358.3,5140,1,4,0)
 ;;=4^E08.59
 ;;^UTILITY(U,$J,358.3,5140,2)
 ;;=^5002530
 ;;^UTILITY(U,$J,358.3,5141,0)
 ;;=E09.51^^34^311^36
 ;;^UTILITY(U,$J,358.3,5141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5141,1,3,0)
 ;;=3^Drug/chem diabetes w diabetic prph angiopath w/o gangrene
 ;;^UTILITY(U,$J,358.3,5141,1,4,0)
 ;;=4^E09.51
 ;;^UTILITY(U,$J,358.3,5141,2)
 ;;=^5002570
 ;;^UTILITY(U,$J,358.3,5142,0)
 ;;=E09.59^^34^311^48
 ;;^UTILITY(U,$J,358.3,5142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5142,1,3,0)
 ;;=3^Drug/chem diabetes w oth circulatory complications
 ;;^UTILITY(U,$J,358.3,5142,1,4,0)
 ;;=4^E09.59
 ;;^UTILITY(U,$J,358.3,5142,2)
 ;;=^5002572
 ;;^UTILITY(U,$J,358.3,5143,0)
 ;;=E08.618^^34^311^20
 ;;^UTILITY(U,$J,358.3,5143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5143,1,3,0)
 ;;=3^Diabetes due to underlying condition w oth diabetic arthrop
 ;;^UTILITY(U,$J,358.3,5143,1,4,0)
 ;;=4^E08.618
 ;;^UTILITY(U,$J,358.3,5143,2)
 ;;=^5002532
 ;;^UTILITY(U,$J,358.3,5144,0)
 ;;=E08.620^^34^311^21
 ;;^UTILITY(U,$J,358.3,5144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5144,1,3,0)
 ;;=3^Diabetes due to underlying condition w diabetic dermatitis
 ;;^UTILITY(U,$J,358.3,5144,1,4,0)
 ;;=4^E08.620
 ;;^UTILITY(U,$J,358.3,5144,2)
 ;;=^5002533
 ;;^UTILITY(U,$J,358.3,5145,0)
 ;;=E08.621^^34^311^22
 ;;^UTILITY(U,$J,358.3,5145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5145,1,3,0)
 ;;=3^Diabetes due to underlying condition w foot ulcer
 ;;^UTILITY(U,$J,358.3,5145,1,4,0)
 ;;=4^E08.621
 ;;^UTILITY(U,$J,358.3,5145,2)
 ;;=^5002534
 ;;^UTILITY(U,$J,358.3,5146,0)
 ;;=E08.622^^34^311^23
 ;;^UTILITY(U,$J,358.3,5146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5146,1,3,0)
 ;;=3^Diabetes due to underlying condition w oth skin ulcer
 ;;^UTILITY(U,$J,358.3,5146,1,4,0)
 ;;=4^E08.622
 ;;^UTILITY(U,$J,358.3,5146,2)
 ;;=^5002535
 ;;^UTILITY(U,$J,358.3,5147,0)
 ;;=E08.628^^34^311^24
 ;;^UTILITY(U,$J,358.3,5147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5147,1,3,0)
 ;;=3^Diabetes due to underlying condition w oth skin comp
 ;;^UTILITY(U,$J,358.3,5147,1,4,0)
 ;;=4^E08.628
 ;;^UTILITY(U,$J,358.3,5147,2)
 ;;=^5002536
 ;;^UTILITY(U,$J,358.3,5148,0)
 ;;=E08.630^^34^311^25
 ;;^UTILITY(U,$J,358.3,5148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5148,1,3,0)
 ;;=3^Diabetes due to underlying condition w periodontal disease
 ;;^UTILITY(U,$J,358.3,5148,1,4,0)
 ;;=4^E08.630
 ;;^UTILITY(U,$J,358.3,5148,2)
 ;;=^5002537
 ;;^UTILITY(U,$J,358.3,5149,0)
 ;;=E08.638^^34^311^26
 ;;^UTILITY(U,$J,358.3,5149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5149,1,3,0)
 ;;=3^Diabetes due to underlying condition w oth oral comp
 ;;^UTILITY(U,$J,358.3,5149,1,4,0)
 ;;=4^E08.638
 ;;^UTILITY(U,$J,358.3,5149,2)
 ;;=^5002538
 ;;^UTILITY(U,$J,358.3,5150,0)
 ;;=E08.649^^34^311^27
 ;;^UTILITY(U,$J,358.3,5150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5150,1,3,0)
 ;;=3^Diabetes due to underlying condition w hypoglycemia w/o coma
 ;;^UTILITY(U,$J,358.3,5150,1,4,0)
 ;;=4^E08.649
 ;;^UTILITY(U,$J,358.3,5150,2)
 ;;=^5002540
 ;;^UTILITY(U,$J,358.3,5151,0)
 ;;=E08.65^^34^311^28
 ;;^UTILITY(U,$J,358.3,5151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5151,1,3,0)
 ;;=3^Diabetes due to underlying condition w hyperglycemia
 ;;^UTILITY(U,$J,358.3,5151,1,4,0)
 ;;=4^E08.65
 ;;^UTILITY(U,$J,358.3,5151,2)
 ;;=^5002541
 ;;^UTILITY(U,$J,358.3,5152,0)
 ;;=E08.69^^34^311^29
 ;;^UTILITY(U,$J,358.3,5152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5152,1,3,0)
 ;;=3^Diabetes due to underlying condition w oth complication
 ;;^UTILITY(U,$J,358.3,5152,1,4,0)
 ;;=4^E08.69
 ;;^UTILITY(U,$J,358.3,5152,2)
 ;;=^5002542
